These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36005472)

  • 1. What Is in the Myopathy Literature?
    Al-Lahham T; Lacomis D
    J Clin Neuromuscul Dis; 2022 Sep; 24(1):38-48. PubMed ID: 36005472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.
    Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T
    Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.
    Munekane A; Ohsawa Y; Okubo M; Nagai T; Nishimura H; Nishino I; Sunada Y
    Intern Med; 2023 May; 62(9):1345-1349. PubMed ID: 36130887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired necrotizing myopathies].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
    Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of necrotizing myopathy.
    Selva-O'Callaghan A; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM
    Curr Opin Rheumatol; 2021 Nov; 33(6):544-553. PubMed ID: 34482348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child.
    Mohassel P; Foley AR; Donkervoort S; Fequiere PR; Pak K; Bönnemann CG; Mammen AL
    Muscle Nerve; 2017 Dec; 56(6):1177-1181. PubMed ID: 28066895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
    Mammen AL
    Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
    Saito Y; Nishino I
    Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Features of Anti-Ku Myositis.
    Oyama M; Holzer MT; Ohnuki Y; Saito Y; Nishimori Y; Suzuki S; Shiina T; Leonard-Louis S; Benveniste O; Schneider U; Stenzel W; Nishino I; Suzuki S; Uruha A
    Neurology; 2024 Apr; 102(8):e209268. PubMed ID: 38547417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis.
    Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T
    Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?
    Mammen AL
    Curr Opin Rheumatol; 2017 Nov; 29(6):618-622. PubMed ID: 28832350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing myopathies: beyond statins.
    Mammen AL
    Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.